Back
Revance Therapeutics Vs. IonQ Industry Stock Comparison
Sell
13
RVNC
Revance Therapeutics
Last Price:
$3.09
Seasonality Move:
-2.77%
Sell
45
IONQ
IonQ
Last Price:
$44.51
Seasonality Move:
-9.31%
Sell
13
Revance Therapeutics (RVNC)
is a Sell
Is Revance Therapeutics a Buy, Sell or Hold?
-
The current Revance Therapeutics [RVNC] share price is $3.08. The Score for RVNC is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
-
RVNC is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
45
IonQ (IONQ)
is a Sell
Is IonQ a Buy, Sell or Hold?
-
IONQ is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RVNC Stock Price Chart
What is Revance Therapeutics's stock price today?
-
The Revance Therapeutics share price today is $3.08The current trend is relatively stagnant and RVNC is experiencing slight buying pressure.
IONQ Stock Price Chart
RVNC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.38 | Sell |
Relative Strength Index (14 RSI): | 33.1 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.14 - 3.96) | Sell |
Bollinger Bands (100): | (3.74 - 6.28) | Sell |
IONQ Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.24 | Buy |
Relative Strength Index (14 RSI): | 65.9 | Buy |
Chaikin Money Flow: | 20919957 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (29.07 - 38.47) | Buy |
Bollinger Bands (100): | (5.3 - 27.66) | Buy |
RVNC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.07 | Buy |
20-day SMA: | 3.46 | Sell |
50-day SMA: | 4.37 | Sell |
200-day SMA: | 4.37 | Sell |
8-day EMA: | 3.14 | Sell |
20-day EMA: | 3.46 | Sell |
50-day EMA: | 4.1 | Sell |
200-day EMA: | 5.56 | Sell |
IONQ Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 37.37 | Buy |
20-day SMA: | 35.02 | Buy |
50-day SMA: | 25.25 | Buy |
200-day SMA: | 12.43 | Buy |
8-day EMA: | 38.72 | Buy |
20-day EMA: | 34.81 | Buy |
50-day EMA: | 27.27 | Buy |
200-day EMA: | 15.8 | Buy |
Revance Therapeutics Earnings Growth & RVNC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.38 per share, and an increase next year of $0.63 per share.
IonQ Earnings Growth & IONQ Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.08 per share, and a decrease next year of $0.06 per share.
Revance Therapeutics Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
IonQ Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |